Ads
related to: genentech
Search results
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate
Benzinga via Yahoo Finance· 1 day agoThursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b...
Americans to get one-time payment from new $250,000 401k settlement
The US Sun· 5 days agoTHOUSANDS of Americans are eligible for a one-time payout of an undisclosed amount following the...
Best Ads of the Week: Coi Leray kicks it with Foot Locker & Dove decodes mom life with AI
The Drum· 2 days agoThis week, Editora Taverna fought the good fight against gay conversion therapy Brazil, Vivo rallied...
Earnings call: Lonza maintains outlook despite Q1 performance lag By Investing.com
Investing.com· 3 days agoLonza Group AG (LONN.SW), a global leader in life sciences, reported a softer performance in the...
Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoLineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2024 Earnings Call Transcript May 10, 2024 Lineage...
Biotech company lays off over a hundred Bay Area workers
San Francisco Chronicle· 19 hours agoBioMarin Pharmaceutical, a San Rafael-based biotech company specializing in drugs for genetic...
Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
Clinical Trials Arena via Yahoo Finance· 2 days agoThe Acclaim-3 trial aims to determine the safety and optimal dosage of Reqorsa (quaratusugene...
Takeda pays AC Immune $100M upfront for Alzheimer's drug as phase 2 readout nears
FierceBiotech· 4 days agoTakeda may be paring back its R&D pipeline in the name of efficiency, but the Japanese pharma has...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced its unaudited financial results
Perioperative Nivolumab Boosts EFS in Resectable Lung Cancer
MedPage Today· 3 days agoCheckMate 77T trial shows 42% reduction in risk of tumor recurrence, progression, or death
Ad
related to: genentech
